Krystal Biotech, Inc. (KRYS)
NASDAQ·Healthcare·Biotechnology
$319.24
+1.78%
Mkt Cap $9.48B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (17 analysts)
$395.20
Range $300.00 – $474.00
Implied Upside
+23.8%
Consensus $395.20 vs current $319.24
NASDAQ·Healthcare·Biotechnology
$319.24
+1.78%
Mkt Cap $9.48B
Buy
12
Hold
0
Sell
0
Price Target (17 analysts)
$395.20
Range $300.00 – $474.00
+23.8%
Consensus $395.20 vs current $319.24